Skip to Content

Metabolic Disorders

Please install or upgrade your Adobe Flash Player to see a video on this topic.

Get Adobe Flash Player logo

Regulation of our body’s blood sugar level is a vital yet delicate balance, which can easily be disrupted. The result is diabetes. The WHO estimates that more than 180 million people worldwide suffer from diabetes.
Type 2 diabetes – the commonest form of the disease – is now recognised globally as a growing epidemic.

Independence for people with diabetes

Diabetes isn’t a disease you can necessarily feel – to detect it and keep it under control, there’s no substitute for regularly checking your blood sugar levels. Testing takes just a single drop of blood and a few minutes. We offer a wide range of products that make it easy for people with diabetes to check their blood sugar levels consistently in day-to-day situations.

Roche –
the leader in diabetes care

For over 30 years our Accu-Chek blood glucose meters have ensured precise and rapid blood sugar measurement both at home and on the move. Not only that, they have become increasingly easy to operate. State-of-the-art measurement, infusion and data processing systems help doctors and patients to implement comprehensive diabetes management and hence optimise treatment.

Tailor-made diabetes self-management solutions help people with diabetes to manage their condition, to live more spontaneously and to improve their quality of life. These key elements of modern diabetes care are covered by 4 Accu-Chek product areas:

  • Accu-Chek blood glucose monitoring systems offering tailor-made solutions for individual needs.
  • Data management solutions to track and display blood glucose results.
  • Insulin delivery systems offering a new level of flexibility in insulin pump therapy.
  • Lancing devices offering less painful testing.

New research strategies focus on metabolism

Researching new drugs against diabetes means taking a patient’s metabolism into account. Recognising that obesity, lipid metabolism disorders and high blood pressure are closely associated with diabetes; Roche is testing various compounds that act at key metabolic interfaces. At the same time we’re using a new comprehensive approach called systems biology to research the central role played by the body’s insulin-producing cells.